Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 2/2014

01-03-2014 | Original Article

Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI

Authors: Piranit Nik Kantaputra, Hülya Kayserili, Yeliz Güven, Warissara Kantaputra, Mehmet C. Balci, Pranoot Tanpaiboon, Anusha Uttarilli, Ashwin Dalal

Published in: Journal of Inherited Metabolic Disease | Issue 2/2014

Login to get access

Abstract

Objective

To assess oral manifestations of 17 patients with mucopolysaccharidosis type VI (MPS VI) or Maroteaux-Lamy syndrome.

Methods

We performed comprehensive oral examinations in 17 patients with MPS VI. Panoramic radiographs was performed only in 14 patients. All patients were of Thai, Turkish, and Indian origins. Ten of 17 patients had enzyme replacement therapy (ERT) (Naglazyme). Most Turkish patients (10/11) were on ERT. The Thai and Indian patients have never had ERT.

Results

Oral and radiographic examinations showed that hypoplastic mandibular condyles (93.3 %), malposition of unerupted teeth (92.9 %), large dental follicles (92.3 %), anterior open bite (86.7 %), maxillary constriction (56.3 %), and taurodontism (53.8 %) were common among patients with MPS VI. Newly recognized oral findings found in our study included taurodontism, long tooth roots, abnormal frenum, missing teeth, supernumerary teeth, and microdontia. Two patients who started ERT prior to 3 years old did not develope anterior open bite and one of them had mildly affected mandibular condyles.

Conclusion

Our study provides the most comprehensive study of oral manifestations in patients with MPS VI. Receiving ERT at very young ages may lessen craniofacial malformations including hypoplasic mandibular condyles and anterior open bite. Oral manifestations can be used as diagnostic features for MPS VI prior to assessing leukocyte ARSB activity or urinary excretion of dermatan sulfate.
Appendix
Available only for authorised users
Literature
go back to reference Alliston T (2010) Chondroitin sulfate and growth factor signaling in the skeleton: possible links to MPS VI. J Pediatr Rehabil Med 3:129–138PubMedCentralPubMed Alliston T (2010) Chondroitin sulfate and growth factor signaling in the skeleton: possible links to MPS VI. J Pediatr Rehabil Med 3:129–138PubMedCentralPubMed
go back to reference Alpöz AR, Coker M, Celen E et al (2006) The oral manifestations of Maroteaux-Lamy syndrome (mucopolysaccharidosis VI): a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:632–637PubMedCrossRef Alpöz AR, Coker M, Celen E et al (2006) The oral manifestations of Maroteaux-Lamy syndrome (mucopolysaccharidosis VI): a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:632–637PubMedCrossRef
go back to reference Azevedo AC, Schwartz L IV, Kalakun L et al (2004) Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI. Clin Genet 66:208–213PubMedCrossRef Azevedo AC, Schwartz L IV, Kalakun L et al (2004) Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI. Clin Genet 66:208–213PubMedCrossRef
go back to reference Braunlin EA, Harmatz PR, Scarpa M (2011) Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis 34:1183–1197PubMedCentralPubMedCrossRef Braunlin EA, Harmatz PR, Scarpa M (2011) Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis 34:1183–1197PubMedCentralPubMedCrossRef
go back to reference Byers S, Rozaklis T, Brumfield LK, Ranieri E, Hopwood JJ (1998) Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS. Mol Genet Metab 65:282–290PubMedCrossRef Byers S, Rozaklis T, Brumfield LK, Ranieri E, Hopwood JJ (1998) Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS. Mol Genet Metab 65:282–290PubMedCrossRef
go back to reference Campos D, Monaga M (2012) Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms. Metab Brain Dis 27:121–129PubMedCrossRef Campos D, Monaga M (2012) Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms. Metab Brain Dis 27:121–129PubMedCrossRef
go back to reference Chen MR, Lin SP, Hwang HK, Yu CH (2005) Cardiovascular changes in mucopolysaccharidoses in Taiwan. Acta Cardiol 60:51–53PubMedCrossRef Chen MR, Lin SP, Hwang HK, Yu CH (2005) Cardiovascular changes in mucopolysaccharidoses in Taiwan. Acta Cardiol 60:51–53PubMedCrossRef
go back to reference Costa-Motta FM, Acosta AX, Abe-Sandes K et al (2011) Genetic studies in a cluster of mucopolysaccharidosis type VI patients in Northeast Brazil. Mol Genet Metab 104:603–607PubMedCrossRef Costa-Motta FM, Acosta AX, Abe-Sandes K et al (2011) Genetic studies in a cluster of mucopolysaccharidosis type VI patients in Northeast Brazil. Mol Genet Metab 104:603–607PubMedCrossRef
go back to reference de Almeida-Barros RQ, Oka SC, Pordeus AC, de Medeiros PF, Bento PM, Godoy GP (2012) Oral and systemic manifestations of mucopolysaccharidosis type VI: a report of seven cases. Quintessence Int 43:e32–e38PubMed de Almeida-Barros RQ, Oka SC, Pordeus AC, de Medeiros PF, Bento PM, Godoy GP (2012) Oral and systemic manifestations of mucopolysaccharidosis type VI: a report of seven cases. Quintessence Int 43:e32–e38PubMed
go back to reference Hu Y, Billiau AD, Verdonck A, Wouters C, Carels C (2009) Variation in dentofacial morphology and occlusion in juvenile idiopathic arthritis subjects: a case-control study. Eur J Orthod 31:51–58PubMedCrossRef Hu Y, Billiau AD, Verdonck A, Wouters C, Carels C (2009) Variation in dentofacial morphology and occlusion in juvenile idiopathic arthritis subjects: a case-control study. Eur J Orthod 31:51–58PubMedCrossRef
go back to reference Isbrandt D, Arlt G, Brooks DA, Hopwood JJ, von Figura K, Peters C (1994) Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes. Am J Hum Genet 54:454–463PubMedCentralPubMed Isbrandt D, Arlt G, Brooks DA, Hopwood JJ, von Figura K, Peters C (1994) Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes. Am J Hum Genet 54:454–463PubMedCentralPubMed
go back to reference Karageorgos L, Brooks DA, Pollard A et al (2007) Mutational analysis of 105 mucopolysaccharidosis type VI patients. Hum Mutat 28:897–903PubMedCrossRef Karageorgos L, Brooks DA, Pollard A et al (2007) Mutational analysis of 105 mucopolysaccharidosis type VI patients. Hum Mutat 28:897–903PubMedCrossRef
go back to reference Kayserili H, Kantaputra PN (2012) Multiple supernumerary molars, anterior open bite, and large ear lobules in mucopolysaccharidosis type VI patient. Am J Med Genet 158A:1798–1800PubMedCrossRef Kayserili H, Kantaputra PN (2012) Multiple supernumerary molars, anterior open bite, and large ear lobules in mucopolysaccharidosis type VI patient. Am J Med Genet 158A:1798–1800PubMedCrossRef
go back to reference Leal GN, de Paula AC, Leone C, Kim CA (2010) Echocardiographic study of paediatric patients with mucopolysaccharidosis. Cardiol Young 20:254–261PubMedCrossRef Leal GN, de Paula AC, Leone C, Kim CA (2010) Echocardiographic study of paediatric patients with mucopolysaccharidosis. Cardiol Young 20:254–261PubMedCrossRef
go back to reference Lin X (2004) Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131:6009–6021PubMedCrossRef Lin X (2004) Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131:6009–6021PubMedCrossRef
go back to reference Lin WD, Lin SP, Wang CH et al (2008) Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients. Clin Chim Acta 394:89–93PubMedCrossRef Lin WD, Lin SP, Wang CH et al (2008) Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients. Clin Chim Acta 394:89–93PubMedCrossRef
go back to reference MacLeod SP, Macintyre DR (1993) Bilateral hypoplasia of mandibular condyles in Hurler’s syndrome. Oral Surg Oral Med Oral Pathol 75:659–660PubMedCrossRef MacLeod SP, Macintyre DR (1993) Bilateral hypoplasia of mandibular condyles in Hurler’s syndrome. Oral Surg Oral Med Oral Pathol 75:659–660PubMedCrossRef
go back to reference Maroteaux P, Leveque B, Marie J, Lamy M (1963) A new dysostosis with urinary elimination of chondroitin sulfate B. Presse Med 71:849–1852 Maroteaux P, Leveque B, Marie J, Lamy M (1963) A new dysostosis with urinary elimination of chondroitin sulfate B. Presse Med 71:849–1852
go back to reference Nakamura T, Miwa K, Kanda S et al (1992) Rosette formation of impacted molar teeth in mucopolysaccharidosis and related disroders. Dentomaxillofac Radiol 21:45–49PubMed Nakamura T, Miwa K, Kanda S et al (1992) Rosette formation of impacted molar teeth in mucopolysaccharidosis and related disroders. Dentomaxillofac Radiol 21:45–49PubMed
go back to reference Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3421–3452 Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3421–3452
go back to reference Ng CS, Wong WK, Hagg U (2008) Orthodontic treatment of anterior open bite. Int J Paediatr Dent 18:78–83PubMed Ng CS, Wong WK, Hagg U (2008) Orthodontic treatment of anterior open bite. Int J Paediatr Dent 18:78–83PubMed
go back to reference Roberts MW, Barton NW, Constantopoulos G, Butler DP, Donahue AH (1984) Occurrence of multiple dentigerous cysts in a patient with the Maroteaux-Lamy syndrome (mucopolysaccharidosis, type VI). Oral Surg Oral Med Oral Pathol 58:169–175PubMedCrossRef Roberts MW, Barton NW, Constantopoulos G, Butler DP, Donahue AH (1984) Occurrence of multiple dentigerous cysts in a patient with the Maroteaux-Lamy syndrome (mucopolysaccharidosis, type VI). Oral Surg Oral Med Oral Pathol 58:169–175PubMedCrossRef
go back to reference Schmidt H, Ullrich K, von Lengerke HJ, Kleine M, Bramswig J (1987) Radiographic findings in patients with mucopolysaccharidosis I H/S (Hurler-Scheie syndrome). Pediatr Radiol 17:409–414 Schmidt H, Ullrich K, von Lengerke HJ, Kleine M, Bramswig J (1987) Radiographic findings in patients with mucopolysaccharidosis I H/S (Hurler-Scheie syndrome). Pediatr Radiol 17:409–414
go back to reference Simonaro CM, Haskins ME, Schuchman EH (2001) Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Lab Investig 81:1319–1328PubMedCrossRef Simonaro CM, Haskins ME, Schuchman EH (2001) Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Lab Investig 81:1319–1328PubMedCrossRef
go back to reference Smith KS, Hallet KB, Hall RK, Wardrop RW, Firth N (1995) Mucopolysaccharidosis: MPS VI and associated delayed tooth eruption. Oral Maxillofacial Surg 24:176–180 Smith KS, Hallet KB, Hall RK, Wardrop RW, Firth N (1995) Mucopolysaccharidosis: MPS VI and associated delayed tooth eruption. Oral Maxillofacial Surg 24:176–180
go back to reference Stevenson RE, Howell RR, McKusick VA et al (1976) The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features. Pediatrics 57:111–122PubMed Stevenson RE, Howell RR, McKusick VA et al (1976) The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features. Pediatrics 57:111–122PubMed
go back to reference Sugahara K, Mikami T, Uyama T, Mizuguchi S, Nomura K, Kitagawa H (2003) Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr Opin Struct Biol 13:612–620PubMedCrossRef Sugahara K, Mikami T, Uyama T, Mizuguchi S, Nomura K, Kitagawa H (2003) Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr Opin Struct Biol 13:612–620PubMedCrossRef
go back to reference Trowbridge JM, Gallo RL (2002) Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 12:117R–125RPubMedCrossRef Trowbridge JM, Gallo RL (2002) Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 12:117R–125RPubMedCrossRef
go back to reference Valayannopoulos V, Nicely H, Harmatz P, Turbeville S (2010) Mucopolysaccharidosis VI, Orphanet. J Rare Dis 5:5–20CrossRef Valayannopoulos V, Nicely H, Harmatz P, Turbeville S (2010) Mucopolysaccharidosis VI, Orphanet. J Rare Dis 5:5–20CrossRef
go back to reference Wang L, Lazebnik M, Detamore MS (2009) Hyaline cartilage cells outperform mandibular condylar cartilage cells in a TMJ fibrocartilage tissue engineering application. Osteoarthritis Cartilage 17:346–353PubMedCrossRef Wang L, Lazebnik M, Detamore MS (2009) Hyaline cartilage cells outperform mandibular condylar cartilage cells in a TMJ fibrocartilage tissue engineering application. Osteoarthritis Cartilage 17:346–353PubMedCrossRef
Metadata
Title
Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI
Authors
Piranit Nik Kantaputra
Hülya Kayserili
Yeliz Güven
Warissara Kantaputra
Mehmet C. Balci
Pranoot Tanpaiboon
Anusha Uttarilli
Ashwin Dalal
Publication date
01-03-2014
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 2/2014
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-013-9645-8

Other articles of this Issue 2/2014

Journal of Inherited Metabolic Disease 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.